Palisade Bio Statistics Share Statistics Palisade Bio has 9.12M
shares outstanding. The number of shares has increased by 304.87%
in one year.
Shares Outstanding 9.12M Shares Change (YoY) 304.87% Shares Change (QoQ) 9.08% Owned by Institutions (%) 17.25% Shares Floating 9.05M Failed to Deliver (FTD) Shares 366,569 FTD / Avg. Volume 16.55%
Short Selling Information The latest short interest is 424.35K, so 4.55% of the outstanding
shares have been sold short.
Short Interest 424.35K Short % of Shares Out 4.55% Short % of Float 4.68% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.16 and the forward
PE ratio is -0.51.
Palisade Bio's PEG ratio is
0.
PE Ratio -0.16 Forward PE -0.51 PS Ratio 0 Forward PS 0.2 PB Ratio 0.31 P/FCF Ratio -0.19 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Palisade Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.24,
with a Debt / Equity ratio of 0.02.
Current Ratio 3.24 Quick Ratio 3.24 Debt / Equity 0.02 Debt / EBITDA -0.01 Debt / FCF -0.01 Interest Coverage -1238.25
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.8M Employee Count 8 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -82.45% in the
last 52 weeks. The beta is 1.39, so Palisade Bio's
price volatility has been higher than the market average.
Beta 1.39 52-Week Price Change -82.45% 50-Day Moving Average 0.82 200-Day Moving Average 1.08 Relative Strength Index (RSI) 33.61 Average Volume (20 Days) 2,214,803
Income Statement
Revenue n/a Gross Profit -3K Operating Income -14.86M Net Income -14.44M EBITDA -14.86M EBIT -14.45M Earnings Per Share (EPS) -10.19
Full Income Statement Balance Sheet The company has 9.82M in cash and 169K in
debt, giving a net cash position of 9.65M.
Cash & Cash Equivalents 9.82M Total Debt 169K Net Cash 9.65M Retained Earnings -135.94M Total Assets 6.67M Working Capital 2.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -12.19M
and capital expenditures 0, giving a free cash flow of -12.19M.
Operating Cash Flow -12.19M Capital Expenditures n/a Free Cash Flow -12.19M FCF Per Share -8.61
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PALI does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PALI is $12,
which is 1804.8% higher than the current price. The consensus rating is "Buy".
Price Target $12 Price Target Difference 1804.8% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 8, 2024. It was a
backward
split with a ratio of 1:15.
Last Split Date Apr 8, 2024 Split Type backward Split Ratio 1:15
Scores Altman Z-Score -34.56 Piotroski F-Score 3
